ID

23898

Beschrijving

Study part: Non- Serious Adverse Events. A phase 2 study to assess safety, reactogenicity and immunogenicity of a booster dose of an investigational vaccination regimen and GSK Biologicals Hib-MenC vaccine (co-administered with Infanrix penta) compared to a booster dose of Menjugate (co-administered with Infanrix hexa).Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Study ID: 100381, Clinical Study ID: 100381

Trefwoorden

Versies (1)
  1. 17-07-17 17-07-17 -
Houder van rechten

GlaxoSmithKline

Geüploaded op

17 juli 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Non- Serious Adverse Events Hib-MenCY-TT-004 BST 003 Neisseria Meningitidis-Haemophilus influenzae type b Vaccine 100381

Engels

Non- Serious Adverse Events

1 Formulieren  
NON-SERIOUS ADVERSE EVENTS
Beschrijving

NON-SERIOUS ADVERSE EVENTS

Alias
UMLS CUI-1
C1518404
Subject number
Beschrijving

Subject number

Datatype

integer

Alias
UMLS CUI [1]
C2348585
Has any non-serious adverse events occurred within one month (minimum 30 days) post-vaccination, excluding those recorded on the Solicited Adverse Events pages?
Beschrijving

non-serious adverse events

Datatype

boolean

Alias
UMLS CUI [1]
C1518404
Description
Beschrijving

Description Non- Serious Adverse Events

Datatype

text

Alias
UMLS CUI [1,1]
C0678257
UMLS CUI [1,2]
C1518404
Administration sites
Beschrijving

site vaccines

Datatype

integer

Alias
UMLS CUI [1,1]
C1515974
UMLS CUI [1,2]
C0042210
Non-administration site
Beschrijving

site vaccines

Datatype

boolean

Alias
UMLS CUI [1,1]
C1515974
UMLS CUI [1,2]
C0042210
Date Started
Beschrijving

Date Started

Datatype

date

Alias
UMLS CUI [1]
C0808070
Date Started-during immediate post-vaccination period (at least 30 minutes)
Beschrijving

Date Started

Datatype

boolean

Alias
UMLS CUI [1]
C0808070
Date Stopped
Beschrijving

Date Stopped

Datatype

date

Alias
UMLS CUI [1]
C0806020
Intensity
Beschrijving

Intensity

Datatype

text

Alias
UMLS CUI [1]
C1710066
Relationship to investigational products: Is there a reasonable possibility that the AE may have been caused by the investigational product?
Beschrijving

adverse event drug study

Datatype

boolean

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0013227
UMLS CUI [1,3]
C0008972
Outcome
Beschrijving

Outcome

Datatype

integer

Alias
UMLS CUI [1]
C1705586
Did the subject seek medical advice?
Beschrijving

medical advice

Datatype

boolean

Alias
UMLS CUI [1]
C1386497
If yes please specify type:
Beschrijving

medical advice

Datatype

integer

Alias
UMLS CUI [1]
C1386497
Terug naar het begin van de pagina

Similar models

Non- Serious Adverse Events

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
NON-SERIOUS ADVERSE EVENTS
C1518404 (UMLS CUI-1)
Subject number
Item
Subject number
integer
C2348585 (UMLS CUI [1])
non-serious adverse events
Item
Has any non-serious adverse events occurred within one month (minimum 30 days) post-vaccination, excluding those recorded on the Solicited Adverse Events pages?
boolean
C1518404 (UMLS CUI [1])
Description Non- Serious Adverse Events
Item
Description
text
C0678257 (UMLS CUI [1,1])
C1518404 (UMLS CUI [1,2])
Item
Administration sites
integer
C1515974 (UMLS CUI [1,1])
C0042210 (UMLS CUI [1,2])
site vaccines
Code List
Administration sites
CL Item
Hib-MenCY OR Hib-MenC vaccine [ 9 0 1 ] (1)
CL Item
MenC vaccine [ 9 0 2 ] (2)
CL Item
DTPa-HBV-IPV vaccine [ 1 4 ] (3)
CL Item
DTPa-HBV-IPV/Hib vaccine [ 3 8 ] (4)
site vaccines
Item
Non-administration site
boolean
C1515974 (UMLS CUI [1,1])
C0042210 (UMLS CUI [1,2])
Date Started
Item
Date Started
date
C0808070 (UMLS CUI [1])
Date Started
Item
Date Started-during immediate post-vaccination period (at least 30 minutes)
boolean
C0808070 (UMLS CUI [1])
Date Stopped
Item
Date Stopped
date
C0806020 (UMLS CUI [1])
Item
Intensity
text
C1710066 (UMLS CUI [1])
Intensity
Code List
Intensity
CL Item
Mild (Mild)
CL Item
Moderate (Moderate)
CL Item
Severe (Severe)
adverse event drug study
Item
Relationship to investigational products: Is there a reasonable possibility that the AE may have been caused by the investigational product?
boolean
C0877248 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0008972 (UMLS CUI [1,3])
Item
Outcome
integer
C1705586 (UMLS CUI [1])
Outcome
Code List
Outcome
CL Item
Recovered / Resolved (1)
CL Item
Recovering / resolving (2)
CL Item
Not recovered / not resolved (3)
CL Item
Recovered with sequelae /Resolved with sequelae (4)
medical advice
Item
Did the subject seek medical advice?
boolean
C1386497 (UMLS CUI [1])
Item
If yes please specify type:
integer
C1386497 (UMLS CUI [1])
medical advice
Code List
If yes please specify type:
CL Item
HO: Hospitalisation (1)
CL Item
ER: Emergency room (2)
CL Item
MD: Medical doctor (3)
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial